【Insights】Accelerating Development of FOLR1 Target to Advance Multidimensional Cancer Therapy

2025-11-05

【Insights】TfR1: Linking Iron Metabolism, Cancer, and Neurological Disorders

2025-11-18

【Insights】Amylin’s Emerging Role in Next-Generation Weight-Loss and Metabolic Therapies

2025-11-19

【Insights】Toll-Like Receptors: Key Components of Innate Immunity

2025-11-27

【Insights】BCMA Drives Accelerated Expansion into the Autoimmune Therapeutics Field

2025-12-04

【Insights】ADCC, ADCP, and CDC: Antibody Structure and Class Considerations

2025-12-12

【Insights】Could GDF15 Become the Next Super Target After PD-1 and GLP-1?

2025-12-17

【Insights】IL-5: a key regulator of eosinophilic inflammation

2025-12-24

【Insights】IL-5: a key regulator of eosinophilic inflammation

2025-12-24

【Insights】Will B7-H3 Become the Next Major ADC Target?

2026-01-22

【Insights】PD-1 Agonists: Insights into Their Growing Impact

2026-01-29

【Insights】TNF-α: Renewed Focus in Autoimmune Disease Therapy

2026-02-05

【Insights】IL-23: A Rising Target in Autoimmune Disease

2026-02-27

【Insights】IL-4 vs. IL-13: Who Will Lead the Next Wave of Autoimmune Therapies?

2026-03-11

【Insights】The IL-17 Pathway Revisited: Mechanistic Maturity and Emerging Opportunities in Immunology

2026-03-25

【Insights】TSLP: A Promising Next-Generation Target in Autoimmune Diseases

2026-04-09

【Insights】GLP-1 Landscape Shift: The Rise of Oral Weight-Loss Therapies

2026-04-15

【Insights】LGR5: A Potential Target for Next-Generation Cancer Therapies

2026-04-23

【Insights】LGR5: A Potential Target for Next-Generation Cancer Therapies

2026-04-23

【Insights】From Deals to Discovery Engines: How Big Pharma Is Redefining Early Drug Development

2026-05-20